drugset
Drugs / Inarigivir soproxil
last change Jan 2021 re-read 2 minutes ago

Inarigivir soproxil

also known as SB9200 · Inarigivir soproxilo · SB-44

Small molecule

Developed for
chronic hepatitis B virus infection · chronic hepatitis C virus infection · hepatitis B virus infection
Investigated by
F-star Therapeutics, Inc. · PRA Health Sciences · CSI Medical Research Pte Ltd · Gilead Sciences · Syneos Health

Trials 5 · a red edge is where a trial was stopped

today NCT04059198 · Ph 2 NCT04023721 · Ph 2 NCT03932513 · Ph 2 NCT03434353 · Ph 2 NCT01803308 · Ph 1
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01803308 Mar 2013 → Aug 2014 chronic hepatitis C virus infection Syneos Health Completed No outcome recorded
Phase 24 trials
Phase 2 NCT04059198 Oct 2019 → Apr 2020 chronic hepatitis B virus infection F-star Therapeutics, Inc. Terminated No outcome recorded
Phase 2 NCT04023721 Jun 2019 → Jul 2020 chronic hepatitis B virus infection F-star Therapeutics, Inc. Terminated No outcome recorded
Phase 2 NCT03932513 Apr → Dec 2019 chronic hepatitis B virus infection F-star Therapeutics, Inc. Terminated No outcome recorded
Phase 2 NCT03434353 Feb 2018 → Jan 2020 chronic hepatitis B virus infection Gilead Sciences Terminated No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02751996 Comparator May 2016 → Feb 2020 hepatitis B virus infection F-star Therapeutics, Inc. Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as inarigivir soproxil ClinicalTrials.gov intervention name — accepted as the source's own label NCT03932513 ↗
3

NCT03434353 ↗

NCT04023721 ↗

NCT04059198 ↗
Known as Inarigivir soproxilo ChEMBL registry synonym — accepted as the source's own label CHEMBL1076930 ↗
Known as SB-44 ChEMBL registry synonym — accepted as the source's own label CHEMBL1076930 ↗
Known as SB9200 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01803308 ↗
1

NCT02751996 ↗
Modality Small molecule — CHEMBL1076930 ↗
Route Oral “Administered orally once daily one hour before or one hour after a meal” NCT03434353 ↗